Inherited disorder characterized by progressive polyuria preceding the decline of renal function and leading to end-stage renal disease during childhood or adolescence.
First reported in the literature in 1945 by Smith and Graham, but the first description is attributed to Guido Fanconi, a Swiss pediatrician, in 1951.
Most frequent genetic cause of end-stage renal disease in childhood. Represents approximately 10 to 15% of end-stage renal disease in children.
Four types of nephronophthisis (NPH) have been reported. It is often determined by the age of the patient at the onset of end-stage renal failure. Terminal renal failure develops at median ages of 1 year, 13 years, and 19 years in NPH II, NPH I, and NPH III, respectively. Type IV is variable.
Type I (Familial Juvenile Nephronophthisis; NPH I): Characterized by anemia, polyuria, polydipsia, isosthenuria, and death in uremia. It represents 80% of all NPH cases.
Type II (Infantile Nephronophthisis; NPH II): Characterized by hypertension, respiratory failure, pulmonary hypoplasia, renal failure by age 3 years, hyperkalemic metabolic acidosis, hyperkalemia, oligohydramnios, and neonatal death secondary to pulmonary insufficiency.
Type III (Adolescent Nephronophthisis; NPH III): Adolescent nephronophthisis is considered clearly distinct by clinical and genetic findings than the other types. Most patients suffered from anemia, and onset of terminal renal failure occurred significantly later than in juvenile nephronophthisis.
Type IV (Nephronophthisis Syndrome; NPH IV): Characterized by a triad of interstitial cell infiltrates, renal tubular cell atrophy with cysts arising from the corticomedullary junction of the kidneys, and renal interstitial fibrosis. Chromosomal localization is reported on a fourth gene locus NPHP4. End-stage renal disease commenced within a wider age range of 11 to 34 years. It usually is considered Type III.
Depends on the clinical form. NPH I (80% of cases) is inherited as a recessive trait (linkage for 2q13; possible second locus 9q22-31). NPH II has recessive inheritance (unknown gene localization). NPH III has no linkage for chromosome 2. NPH IV (medullary cystic disease) is transmitted as an autosomal trait (gene map locus 1q21).
Changes are characteristic and include the presence of atrophic tubules, irregularly thickened tubular basement membrane, and focal interstitial fibrosis. As the disease progresses, diffuse tubulointerstitial changes and medullary cysts are found. The biochemical defect underlying the production of the defective tubular basement membrane is unknown.
Confirmed by pathologic renal findings obtained from biopsy.
Patients will complain of polyuria caused by decreased renal concentrating ability. Progressive renal function deterioration follows. Other features of the disease are growth retardation, cerebellar dysfunction, liver involvement, and bone anomalies. Ocular involvement is common. ...